Curaleaf (OTCMKTS:CURLF) Shares Gap Up – Still a Buy?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) gapped up prior to trading on Monday . The stock had previously closed at $3.41, but opened at $10.22. Curaleaf shares last traded at $9.9125, with a volume of 47,784 shares changing hands.

Analyst Ratings Changes

Separately, Zacks Research lowered Curaleaf from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, June 3rd. Two research analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy”.

Curaleaf Price Performance

The company has a market capitalization of $6.83 billion, a PE ratio of -75.15 and a beta of 1.53. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.56 and a quick ratio of 0.74. The stock’s 50 day simple moving average is $7.64 and its 200-day simple moving average is $7.58.

Curaleaf (OTCMKTS:CURLF) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.27 EPS for the quarter, beating the consensus estimate of ($0.24) by $0.51. Curaleaf had a negative net margin of 7.76% and a negative return on equity of 8.11%. The business had revenue of $324.23 million during the quarter, compared to analyst estimates of $316.62 million. As a group, equities analysts forecast that Curaleaf Holdings, Inc. will post -0.1 earnings per share for the current fiscal year.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.